510(k) Report

510(k) · Cleared

Recalled · Class II · 2012

Durom Hip Resurfacing System, Femoral Components

K070292510(k) TraditionalCleared Apr 26, 200785-day reviewClass II21 CFR 888.3400Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Zimmer GmbH · KXA Prosthesis, Hip, Femoral, Resurfacing

Cleared on Apr 26, 2007 as substantially equivalent to K021799 (Biomet Orthopedics, Inc., 2002) and 3 other predicates after an 85-day review. Its family tree reaches back 4 generations to 1998. It has been recalled 3 times.

Decided
Apr 26, 2007
Review
85 days
Class
Class II
Product code
KXA
Recalls
3
Predicates
4

Its longest line of descent runs back 4 generations to K983452 (1998). 7 ancestors in all, the oldest K811718 (1981). No later device cites it as a predicate yet.

  1. Root · 4 generations backK983452 Nelson Resurfacing HeadBiomet, Inc. · 1998
  2. 3 generations backK021799 Cemented Femoral Head Resurfing DeviceBiomet Orthopedics, Inc. · 2002
  3. 2 generations backK023188 Press-Fit Head Resurfacing DeviceBiomet Orthopedics, Inc. · 2002
  4. 1 generation backK043542 Biopro Tara Femoral Resurfacing ComponentBiopro, Inc. · 2005
  5. This deviceK070292 Durom Hip Resurfacing System, Femoral ComponentsZimmer GmbH · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K983452Nelson Resurfacing HeadBiomet, Inc.1998—
−3K021799Cemented Femoral Head Resurfing DeviceBiomet Orthopedics, Inc.2002—
−2K023188Press-Fit Head Resurfacing DeviceBiomet Orthopedics, Inc.2002—
−1K043542Biopro Tara Femoral Resurfacing ComponentBiopro, Inc.2005—
0 (this device)K070292Durom Hip Resurfacing System, Femoral ComponentsZimmer GmbH2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198110
200010
200310
FIG. 1 — Lineage of K070292, 1998–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KXA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KXA device

  1. #1 K201219 Biocore9 Femoral Head Resurfacing Componentscore 0.7 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021799Cemented Femoral Head Resurfing Device
Summary page 1
…edics/87/KXA Predicate Devices: Cemented Femoral Head Resurfacing Device, manufactured by Biomet Orthopedics, K02 1799, cleared June 26, 2002. DePuy ASRIm Resurfacing Fem…
Biomet Orthopedics, Inc.2002—
*K032659Depuy Asr Resurfacing Femoral Heads
Summary page 1
…d June 26, 2002. DePuy ASRIm Resurfacing Femoral Heads, manufactured by DePuy Orthopaedics, K032659, cleared December 4, 2003. BIOPRO TARA Femoral Resu…
DePuy Orthopaedics, Inc.200313
*K043542Biopro Tara Femoral Resurfacing Component
Summary page 1
…December 4, 2003. BIOPRO TARA Femoral Resurfacing Component, manufactured by BioPro, Inc., K043542, cleared May 18, 2005. The Cormet 2000 Hemi Hip Met…
Biopro, Inc.2005—
*K994153Cormet 2000 Hemi Hip Metallic Resurfacing Prosthesis
Summary page 1
…The Cormet 2000 Hemi Hip Metallic Resurfacing Prostheses, manufactured by Corin Medical, K994 153, cleared February 25, 2000. Device Description: The Durom®Hip Resurfacing System femoral…
Corin USA2000—

Also cleared against K021799: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 4, 2012Class IIZ-0216-2013Error in labelingZimmer Inc., is initiating a correction to the patient labels of products manufactured before March 20I0 by the Zimmer GmbH production site in Wintetthur, Switzerland, after receiving four complaints of a discrepancy between product…
Sep 26, 2007Not classifiedZ-0276-2008Packaging process controlMislabeled as to size; 54mm package contains 46 mm device and vice versa.
Sep 26, 2007Not classifiedZ-0275-2008Packaging process controlMislabeled as to size; 54mm package contains 46 mm device and vice versa.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 4 companies; a new generation was cleared every 2.4 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K021799.

How does its category compare?

All KXA devices

KXA Prosthesis, Hip, Femoral, Resurfacing: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · KXA

1in 2021

2007: 22008: 12010: 12021: 1
2007high 2 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KXA

Too few KXA 510(k)s in any year since 2007 to give a median.

Recalls per year · KXA

1in 2012

2007: 22010: 132012: 1
2007high 13 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KXA

14in 2025

2007: 152008: 222009: 112010: 682011: 5932012: 2,0992013: 2,5222014: 2,4312015: 1,6742016: 6212017: 5802018: 4302019: 9712020: 3732021: 172022: 132023: 52024: 22025: 14
2007high 2,522 (2013) · low 2 (2024)2025

MAUDE reports naming product code KXA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—215
20081—022
20090—011
20101—1368
20110—0593
20120—12,099
20130—02,522
20140—02,431
20150—01,674
20160—0621
20170—0580
20180—0430
20190—0971
20200—0373
20211—017
20220—013
20230—05
20240—02
20250—014
20260—0—

What is it indicated for?

FOR HEMI-HIP RESURFACING ARTHROPLASTY: The Durom Hip Resurfacing system femoral component, when used for hemi-hip arthroplasty, has been designed for cemented use in patients who are likely to outlive a conventional hip prosthesis. Femoral hip resurfacing hemi arthroplasty is most appropriate for patients with good bone quality in the femoral head and acetabulum, where the bearing surface and supportive bone structure of the acetabulum is normal, and…

Read the full statement (234 words)

FOR HEMI-HIP RESURFACING ARTHROPLASTY:

The Durom Hip Resurfacing system femoral component, when used for hemi-hip arthroplasty, has been designed for cemented use in patients who are likely to outlive a conventional hip prosthesis. Femoral hip resurfacing hemi arthroplasty is most appropriate for patients with good bone quality in the femoral head and acetabulum, where the bearing surface and supportive bone structure of the acetabulum is normal, and where acetabular replacement is neither required nor desirable. Such patients will generally be under the age of 65.

* Non inflammatory degenerative joint disease (NIDJD), e.g. avascular necrosis if remaining bone stock is adequate, and osteoarthritis

* Inflammatory joint disease (IJD), e.g. rheumatoid arthritis

* Joint replacements may be considered for younger patients if any unequivocal indication outweighs the risks associated with the age of the patient and modified demands regarding activity and hip joint loading are assured. This includes severely crippled patients with multiple joint involvement for whom an immediate need of hip mobility leads to an expectation of significant improvement in the quality of their lives

Additional indications include other abnormalities where major pathology affects the femoral head; where the bearing surface and supportive bone structure of the acetabulum is normal; and where acetabular replacement is neither required nor desirable

* WARNING: The Durom Femoral component is not approved for use with the Durom Acetabular cup for total hip surface replacement arthroplasty in the USA.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070292: Durom Hip Resurfacing System, Femoral Components.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070292

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026